Inflammatory Proteins in Plasma and the Risk of Dementia: The Rotterdam Study

Archives of Neurology

Volumn 61, Issue 5, 2004, Pages 668-672

  Engelhart, Marianne J ^a   Geerlings, Mirjam I ^a,b   Meijer, John ^c   Kiliaan, Amanda ^c,d   Ruitenberg, Annemieke ^a   Van Swieten, John C ^a   Stijnen, Theo ^a   Hofman, Albert ^a   Witteman, Jacqueline C M ^a   Breteler, Monique M B ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c NUMICO RESEARCH   (Netherlands)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; C REACTIVE PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; CORRELATION ANALYSIS; DEMENTIA; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; EARLY DIAGNOSIS; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RISK FACTOR;

AGED; ALPHA 1-ANTICHYMOTRYPSIN; BLOOD PROTEINS; C-REACTIVE PROTEIN; CELL ADHESION MOLECULES; COHORT STUDIES; DEMENTIA; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; VASCULAR CELL ADHESION MOLECULE-1;

EID: 2442533101     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.61.5.668     Document Type: Article

References (28)

1. Akiyama H, Barger S, Barnum S, et al. Inflammation and Alzheimer's disease. Neurobiol Aging. 2000;21:383-421.
2. Matsubara E, Hirai S, Amari M, et al. Alpha 1-antichymotrypsin as a possible biochemical marker for Alzheimer-type dementia. Ann Neurol. 1990;28:561-567.
3. Licastro F, Pedrini S, Caputo L, et al. Increased plasma levels of interleukin-1, interleukin-6 and α1-antichymotrypsin in patients with Alzheimer's disease: peripheral inflammation or signals from the brain? J Neuroimmunol. 2000;103:97-102.
4. DeKosky ST, Ikonomovic MD, Wang X, et al. Plasma and cerebrospinal fluid α1-antichymotrypsin levels in Alzheimer's disease: correlation with cognitive impairment. Ann Neurol. 2003;53:81-90.
5. Strandberg TE, Tilvis RS. C-reactive protein, cardiovascular risk factors, and mortality in a prospective study in the elderly. Arterioscler Thromb Vasc Biol. 2000; 20:1057-1060.
6. Kalman J, Juhasz A, Laird G, et al. Serum interleukin-6 levels correlate with the severity of dementia in Down syndrome and in Alzheimer's disease. Acta Neurol Scand. 1997;96:236-240.
7. Schmidt R, Schmidt H, Curb D, Masaki K, White LR, Launer LJ. Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia Aging Study. Ann Neurol. 2002;52:168-174.
8. Yaffe K, Lindquist K, Penninx BW, et al. Inflammatory markers and cognition in well-functioning African American and white elders. Neurology. 2009;61:76-80.
9. Weaver JD, Huang MH, Albert M, Harris T, Rowe JW, Seeman TE. Interleukin-6 and risk of cognitive decline: MacArthur studies of succesful aging. Neurology. 2002;59:371-378.
10. Hofman A, Ott A, Breteler MMB, et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet. 1997; 349:151-154.
11. Ruitenberg A, Ott A, van Swieten JC, Hofman A, Breteler MMB. Incidence of dementia: does gender make a difference? Neurobiol Aging. 2001;22:575-580.
12. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12:189-198.
13. Copeland JRM, Kelleher MJ, Kellett JM, et al. A semi-structured clinical interview for the assessment of diagnosis and mental state in the elderly: the Geriatric Mental State Schedule, I: development and reliability. Psychol Med. 1976; 6:439-449.
14. Roth M, Tym E, Mountjoy CO, et al. CAMDEX: a standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychiatry. 1986;149:698-709.
15. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition. Washington, DC: American Psychiatric Association; 1987.
16. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939-944.
17. Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies: report of the NINDS-AIREN International Workshop. Neurology. 1993;43:250-250.
18. van der Meer IM, de Maat MP, Bots ML, et al. Inflammatory mediators and cell adhesion molecules as indicators of severity of atherosclerosis: the Rotterdam Study. Arterioscler Thromb Vasc Biol. 2002;22:838-842.
19. Barlow WE, Ichikawa L, Rosner D, Izumi S. Analysis of case-cohort designs. J Clin Epidemiol. 1999;52:1165-1172.
20. Eikelenboom P, Verhuis R. The importance of inflammatory mehanisms for the development of Alzheimer's disease. Exp Gerontol. 1999;34:453-461.
21. in 't Veld BA, Ruitenberg A, Hofman A, et al. Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease. N Engl J Med. 2001;345:1515-1521.
22. McGeer PL, Schulzer M, McGeer EG. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies. Neurology. 1996;47:425-432.
23. Abraham CR. Reactive astrocytes and α1-antichymotrypsin in Alzheimer's disease. Neurobiol Aging. 2001;22:931-936.
24. Zhang S, Janciauskiene S. Multi-functional capability of proteins: α1-antichymotrypsin and the correlation with Alzheimer's disease. J Alzheimer's Dis. 2002;4:115-122.
25. Banks WA, Kastin AJ. Passage of peptides across the blood-brain barrier: pathophysiological perspectives. Life Sci. 1996;59:1923-1943.
26. Saija A, Princi P, Lanza M, Scalese M, Aramnejad E, De Sarro D. Systemic cytokine administration can affect blood-brain barrier permeability in the rat. Life Sci. 1995;56:775-784.
27. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med. 1999;340: 115-126.
28. De Simoni MG, De Luigi A, Gemma L, Sironi M, Manfridi A, Ghezzi P. Modulation of systemic interleukin-6 induction by central interleukin-1. Am J Physiol. 1993;265:R739-R742.